Investigational Drug Details
| Drug ID: | D161 |
| Drug Name: | HEC96719 |
| Synonyms: | -- |
| Type: | Chemical drug |
| DrugBank ID: | -- |
| DrugBank Description: | -- |
| PubChem ID: | -- |
| CasNo: | -- |
| Repositioning for NAFLD: | No |
| SMILES: | -- |
| InChiKey: | -- |
| Molecular Weight: | -- |
| DrugBank Targets: | -- |
| DrugBank MoA: | -- |
| DrugBank Pharmacology: | -- |
| DrugBank Indication: | -- |
| Targets: | -- |
| Therapeutic Category: | -- |
| Clinical Trial Progress: | Phase 1 completed (NCT04546984) |
| Latest Progress: | Under clinical trials |
| Trial ID | Source ID | Phases | Status | Study Results | Start Date | Last Update Posted | |
|---|---|---|---|---|---|---|---|
| L0128 | NCT04422496 | Phase 1 | Completed | No Results Available | August 10, 2020 | May 7, 2021 | Details |
| L0297 | NCT04546984 | Phase 1 | Completed | No Results Available | September 14, 2020 | May 7, 2021 | Details |
| L0302 | NCT04194242 | Phase 1 | Completed | No Results Available | January 3, 2020 | December 28, 2020 | Details |
| Target ID | Target Name | GENE | Action | Class | UniProtKB ID | Entry Name |
|---|
| Strategy ID | Strategy | Synonyms | Related Targets | Related Drugs |
|---|